Skip to main content
OpenTrials

Clinical trial condition

Thyroid Eye Disease

Explore clinical trials studying Thyroid Eye Disease. Study availability and eligibility vary by location and protocol.

53 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Eye Disease trial results

Completed

Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT05987423

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Thrive Health Research LLC Beverly Hills, California, United States
  • UCSD Shiley Eye Center La Jolla, California, United States
  • Grene Vision Group, LLC Wichita, Kansas, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 46 locations
View Trial Details
Completed

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT07155668

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • United Medical Research Institute Inglewood, California, United States
  • C&A Clinical Trials Corp Cape Coral, Florida, United States
  • Ilumina Medical Research Kissimmee, Florida, United States
  • Med-Care Research Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

NCT05524571

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Site Number -1520 Pasadena, California, United States
  • Site Number -1517 San Francisco, California, United States
  • Site Number -1514 Torrance, California, United States
  • Site Number -1510 Sarasota, Florida, United States
View all 45 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

NCT06226545

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +15 more
Locations
  • Site 111 Beverly Hills, California, United States
  • Site 105 Palo Alto, California, United States
  • Site 101 San Diego, California, United States
  • Site 103 Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

NCT05517421

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Site Number - 1557 Beverly Hills, California, United States
  • Site Number - 1539 Carlsbad, California, United States
  • Site Number - 1502 Los Angeles, California, United States
  • Site Number - 1505 Los Angeles, California, United States
View all 93 locations
View Trial Details
Completed

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

NCT05683496

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Clinical Research Site Jacksonville, Florida, United States
  • Clinical Research Site Atlanta, Georgia, United States
  • Clinical Research Site Ann Arbor, Michigan, United States
  • Clinical Research Site East Setauket, New York, United States
View Trial Details

Related conditions